Spotlight on Luca Marchesotti of Gemmo

Guiding big corporates and SMEs towards their AI transformation

Luca Marchesotti is the founder of Gemmo, an IPBN member company founded in Dublin in 2022. Armed with a PhD in AI and over a decade's worth of on-the-ground experience at Xerox and as the founder of Beautifeye, Luca is the self-proclaimed "AI nerd who can talk." Luca used his skillset to create a bespoke model service that is very much driven by the needs of the client.

So what is Gemmo? Luca described the company saying, "The bottom line is, we are guiding big corporates and SMEs towards their AI transformation. We do this by making and training AI agents for them." And it's not exclusively for any one sector, as Gemma can be applied to multiple markets from finance to healthcare, to manufacturing among others.

Luca explained, "We're all engineers, so we're pragmatic, we get to the point, we identify with the customer what the top two or three use cases that are worth solving are, and then we create a bespoke solution. These bespoke agents are then deployed into their cloud. That's pretty much it."

Through Gemmo, human augmentation can be achieved. It expands employees' abilities to scale, deal with tasks, and train the agents simultaneously and seamlessly in three phases.

Phase one is the discovery phase where employees train the Gemmo agents. Phase two is agents' deployment where bottlenecks can be mitigated if the company wants to scale. Phase three is expansion through the agency model. It's not only simple, it's straightforward.

Luca said, "So think about a company as a group of people and processes. At the moment, almost 80% to 90% of every company's process (and we're talking about big companies) is made up of anywhere from 1K to 3K processes that are developed, deployed, and run by humans. We can bring that down to about 25% so that companies achieve full scalability, even if the business is very complex."

In terms of case studies, Luca pointed to a recent three-phase process completed with a client in the pharmaceutical industry. These companies have to spend a lot of time and money on managing live animal testing. These experiments make it possible to fast-track vaccines and ensure medicines are safe for human consumption. 

Luca said, "Believe it or not, sometimes there are anywhere from 3,000 to 10,000 receptacles...and there are still humans that are going there to inject, monitor, and record what they see." Is the subject lethargic? How many times does it drink water? How is their appetite? These signals can tell scientists a lot, but it is time-consuming and challenging to ensure all the data is witnessed and recorded. Luca clarified, "We are talking about billions at stake."

He added, "If you can shortcut that process by 10 to 20%, it's not only billions in their pocket, but it's also saving people's lives. It's not taking five years anymore, it's taking seven months to develop a new product for cancer, for example." That's why Gemmo is proud to have helped a leading manufacturer of the receptacles to make them smarter, very smart."

These receptacles are equipped with multiple high-resolution cameras, sensors, and microphones that can capture each subject's movements. "We developed AI agents that can understand the behavior of the animals, so we can understand what they do, how they are drinking and sleeping, if they are sick, and so on. It resulted in a dramatic reduction in pre-clinical trial costs, time to deployment, and potentially harmful human interaction and cross-contamination with the animal."

All this to say that their simple intervention yielded incredible amounts of data sets and no one had to sit there with a pen, paper, and stopwatch to produce them. 

Gemmo believes that its bespoke approach can give the same relief and advancement to multiple industries by using the same technological foundations. Essentially, AI is for everyone because it can generate value across a wide range of pain points.

Luca added, "I can be the facilitator. I can help companies discover the most profitable use cases and then deploy and maintain the one that is the killer application."

If anyone from the IPBN is interested in learning more, Luca invites you to a free AI clinic that he created for anyone from CFO to product managers and beyond. He said, "I have seen hundreds of use cases, hundreds of people like them, so I know their pains, I know what's at stake, and I know how to guide them towards AI value." 

He concluded with one final thought, "What makes my expertise particularly unique is that I'm an AI nerd who can talk."